Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $2.84 Million - $3.2 Million
-84,793 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $38,189 - $48,560
1,141 Added 1.36%
84,793 $3.12 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $2,476 - $2,905
78 Added 0.09%
83,652 $3.07 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $2,771 - $3,361
-92 Reduced 0.11%
83,574 $2.73 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $321,332 - $459,114
11,888 Added 16.56%
83,666 $2.73 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $39,997 - $45,392
1,215 Added 1.72%
71,778 $2.81 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $49,254 - $63,869
1,516 Added 2.2%
70,563 $2.54 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $21,004 - $23,583
568 Added 0.83%
69,047 $2.99 Million
Q1 2019

May 16, 2019

SELL
$37.5 - $41.2 $1.09 Million - $1.2 Million
-29,156 Reduced 29.86%
68,479 $2.91 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $71,477 - $81,491
1,858 Added 1.94%
97,635 $4.26 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $179,037 - $217,161
5,194 Added 5.73%
95,777 $4.22 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $37,168 - $39,625
1,127 Added 1.26%
90,583 $3.29 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $382 - $444
12 Added 0.01%
89,456 $3.18 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $294,716 - $312,704
-8,861 Reduced 9.01%
89,444 $3.13 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $3.05 Million - $3.36 Million
98,305
98,305 $3.51 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bontempo Ohly Capital Mgmt LLC Portfolio

Follow Bontempo Ohly Capital Mgmt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bontempo Ohly Capital Mgmt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bontempo Ohly Capital Mgmt LLC with notifications on news.